Health Canada
NOTICE
Updated guidance on preparing and submitting summary reports for marketed drugs and natural health products: Notice
Published: 9/4/2026Detected: 9/4/2026
Summary preview
Updated guidance on preparing and submitting summary reports for marketed drugs and natural health products, which may tighten and standardize reporting expectations across safety, quality, and labeling-related…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#Health Canada
#summary report
#marketed drugs
#natural health products
#post-market
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/2/2026
- Advisory Committee: National Pharmacare Committee of Experts10/2/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/2/2026
- Advisory Committee: Expert Task Force on Substance Use10/2/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/2/2026